Celldex Therapeutics Inc Earnings
The next earnings date for Celldex Therapeutics Inc has not yet been scheduled.
Analyst Estimates of Celldex Therapeutics Inc Earnings
No Results.
| Report Date | Estimated Earnings Per Share |
|---|
No Results. |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Celldex Therapeutics Inc Earnings: Historical
| Report Date | Before/After Market | Earnings Per Share | Surprise % |
|---|
| 03/02/2026 | --- | $-1.22 | -22.00% |
| 11/05/2025 | --- | $0 | 100.00% |
| 08/07/2025 | --- | $0 | 100.00% |
| 05/05/2025 | Before Market | $-0.81 | -17.39% |
| 02/24/2025 | Before Market | $-0.71 | 0.64% |
| 10/31/2024 | Before Market | $-0.64 | 4.48% |
| 08/08/2024 | After Market | $-0.54 | 8.47% |
| 05/06/2024 | After Market | $-0.56 | 18.84% |
| 02/26/2024 | Before Market | $-0.83 | -12.16% |
| 11/02/2023 | After Market | $-0.81 | -19.12% |
| 08/08/2023 | After Market | $-0.65 | 2.99% |
| 05/04/2023 | After Market | $-0.62 | 1.59% |
| 02/28/2023 | After Market | $-0.56 | 5.08% |
| 11/09/2022 | After Market | $-0.57 | 1.72% |
| 08/08/2022 | After Market | $-0.59 | -15.69% |
| 05/05/2022 | After Market | $-0.49 | -8.89% |
| 02/28/2022 | After Market | $-0.43 | -2.38% |
| 11/09/2021 | After Market | $-0.45 | -25.00% |
| 08/05/2021 | After Market | $-0.34 | 15.00% |
| 05/06/2021 | After Market | $-0.42 | -21.74% |
| 03/29/2021 | After Market | $-0.55 | -48.65% |
| 11/05/2020 | After Market | $-0.36 | 0.00% |
| 08/06/2020 | After Market | $-0.50 | 13.79% |
| 05/06/2020 | After Market | $-0.73 | -2.82% |
| 03/26/2020 | After Market | $-0.64 | 28.89% |
| 11/12/2019 | Before Market | $-0.75 | 10.71% |
| 08/07/2019 | After Market | $-0.84 | 28.21% |
| 05/07/2019 | After Market | $-1.40 | -22.81% |
| 03/07/2019 | After Market | $-0.81 | 32.50% |
| 11/07/2018 | After Market | $-0.60 | 73.33% |
| 08/08/2018 | After Market | $-1.65 | 21.43% |
| 05/10/2018 | Before Market | $-0.90 | 70.30% |
| 03/07/2018 | After Market | $-2.55 | 31.27% |
| 11/07/2017 | Before Market | $-3 | 24.43% |
| 08/08/2017 | After Market | $-3.45 | 15.65% |
| 05/09/2017 | After Market | $-3.75 | 12.38% |
| 03/14/2017 | After Market | $-4.50 | 10.71% |
| 11/07/2016 | After Market | $-4.35 | 12.47% |
| 08/08/2016 | After Market | $-4.80 | 4.95% |
| 05/05/2016 | Before Market | $-5.25 | -0.38% |
| 02/23/2016 | Before Market | $-4.95 | 4.81% |
| 11/05/2015 | After Market | $-4.80 | 8.22% |
| 08/10/2015 | After Market | $-4.95 | 2.94% |
| 04/29/2015 | Before Market | $-4.95 | 9.34% |
| 02/24/2015 | Before Market | $-5.40 | -2.27% |
| 11/05/2014 | Before Market | $-4.65 | 6.06% |
| 08/06/2014 | --- | $-4.80 | 0.83% |
| 05/01/2014 | --- | $-4.95 | -25.63% |
| 03/03/2014 | --- | $-4.05 | 3.11% |
| 11/08/2013 | --- | $-4.35 | -18.85% |
| 08/06/2013 | --- | $-3.60 | -7.78% |
| 05/02/2013 | --- | $-3.45 | -4.55% |
| 03/07/2013 | --- | $-4.05 | -8.00% |
| 11/01/2012 | --- | $-3.75 | -3.59% |
| 08/10/2012 | --- | $-3.45 | 8.97% |
| 05/03/2012 | --- | $-4.05 | -13.45% |
| 03/07/2012 | --- | $-4.35 | -4.32% |
| 11/02/2011 | --- | $-4.05 | -5.47% |
| 08/03/2011 | --- | $-4.05 | 5.59% |
| 05/04/2011 | --- | $-4.65 | -2.42% |
| 03/03/2011 | --- | $-3.60 | -214.29% |
| 11/02/2010 | --- | $-4.35 | 10.68% |
| 08/04/2010 | --- | $-4.50 | -13.92% |
| 05/04/2010 | --- | $-3.15 | 20.25% |
| 03/04/2010 | --- | $-6.45 | -50.00% |
| 11/04/2009 | --- | $-6.75 | 18.87% |
| 08/05/2009 | --- | $-8.25 | -16.20% |
| 05/05/2009 | --- | $-7.35 | -6.52% |
| 02/27/2009 | --- | $-7.05 | 12.96% |
| 11/05/2008 | --- | $-7.50 | -4.17% |
| 08/06/2008 | --- | $-10.05 | -19.64% |
| 05/19/2008 | --- | $-32.85 | -229.49% |
| 02/27/2008 | --- | $-26.19 | --- |
| 10/31/2007 | --- | $-12.60 | 0.00% |
| 08/02/2007 | --- | $-12.60 | 30.00% |
| 05/03/2007 | --- | $-12.60 | 12.50% |
| 03/07/2007 | --- | $-14.40 | 0.00% |
| 11/01/2006 | --- | $-14.40 | -14.29% |
| 08/02/2006 | --- | $-14.40 | -14.29% |
| 05/09/2006 | --- | $-7.20 | -33.33% |
| 03/08/2006 | --- | $-9 | 16.67% |
| 10/27/2005 | --- | $-10.80 | 14.29% |
| 08/03/2005 | --- | $-10.80 | -71.43% |
| 05/05/2005 | --- | $-12.60 | -7.69% |
| 03/02/2005 | --- | $-9 | 16.67% |
| 10/20/2004 | --- | $-8.98 | --- |
| 07/22/2004 | --- | $-9 | 0.00% |
| 04/21/2004 | --- | $-5.40 | 40.00% |
| 02/24/2004 | --- | $-9 | 0.00% |
| 10/22/2003 | --- | $-5.40 | 50.00% |
| 07/23/2003 | --- | $-9.48 | --- |
| 04/30/2003 | --- | $-10.01 | --- |
| 02/26/2003 | --- | $-10.80 | 14.29% |
| 10/23/2002 | --- | $-1.80 | 88.89% |
| 07/24/2002 | --- | $-16.20 | 5.26% |
| 04/24/2002 | --- | $-14.40 | 20.00% |
| 02/26/2002 | --- | $-19.80 | 2.94% |
| 10/25/2001 | --- | $-19.80 | 15.38% |
| 08/02/2001 | --- | $-18 | 21.05% |
| 04/25/2001 | --- | $-12.60 | 22.22% |
| 03/01/2001 | --- | $-14.40 | -6.67% |
| 12/14/2000 | --- | $-9 | 0.00% |
| 06/30/2000 | --- | $-9.79 | --- |
| 04/27/2000 | --- | $-7.20 | 33.33% |
| 02/19/1997 | --- | $-16.20 | 10.00% |
| 11/06/1996 | --- | $-18 | 0.00% |
| 07/23/1996 | --- | $-39.60 | -120.00% |
| 02/27/1996 | --- | $-28.80 | -14.29% |
| 11/10/1995 | --- | $-32.40 | -20.00% |
| 08/11/1995 | --- | $-27 | -7.14% |
| 05/12/1995 | --- | $-25.20 | -7.69% |
| 02/15/1995 | --- | $-19.80 | 43.59% |
| 11/10/1994 | --- | $-23.40 | 3.70% |
| 08/02/1994 | --- | $-23.40 | 7.14% |
| 05/02/1994 | --- | $-19.80 | 21.43% |
| 10/29/1993 | Before Market | $-27 | -25.00% |
| 05/12/1993 | Before Market | $-23.40 | -30.00% |
More About Celldex Therapeutics Inc
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.
“Celldex Therapeutics Inc Earnings” Can Refer to the Celldex Therapeutics Inc Earnings Date
Some people say “Celldex Therapeutics Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Celldex Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Celldex Therapeutics Inc Stock on the Earnings Date
If you own Celldex Therapeutics Inc stock (CLDX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Celldex Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Celldex Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Celldex Therapeutics Inc Earnings
You can contact us any time if you would like to ask questions about Celldex Therapeutics Inc earnings or anything else related to the stock market.